| Escherichia coli | Klebsiella species | Staphylococcus aureus | Staph species (non-aureus) | Group B Strep | Beta-hemolytic Streptococcus |
---|---|---|---|---|---|---|
Cefixime | 82/119a (68.9%) | 34/36 (94.4%) | 0/7 | 4/28 (14.3%) | 4/7 (57.1%) | 11/11 (100.0%) |
Nitrofurantoin | 117/118 (99.2%) | 26/35 (74.3%) | 7/7 (100.0%) | 28/28 (100.0%) | 7/7 (100.0%) | 11/11 (100.0%) |
Ampicillin | 40/119 (33.6%) | 3/36 (8.3%) | 3/7 (42.9%) | 16/28 (57.1%) | 7/7 (100.0%) | 10/11 (90.9%) |
Azithromycin | 34/120 (28.3%) | 3/36 (8.3%) | 3/7 (42.9%) | 22/28 (78.6%) | 2/7 (28.6%) | 6/11 (54.5%) |
Cotrimoxazole | 74/118 (62.7%) | 35/36 (97.2%) | 6/7 (85.7%) | 23.28 (82.1%) | 7/7 (100.0%) | 11/11 (100.0%) |
Gentamicin | 97/117 (82.9%) | 33/36 (91.7%) | 6/7 (85.7%) | 24/28 (85.7%) | 3/7 (42.9%) | 2/7 (18.2%) |
Nalidixic acid | 45/121 (37.2%) | 33/36 (91.7%) | 0/7 (0.0%) | 5/28 (17.9%) | 0/7 (0.0%) | 0/11 (0.0%) |
Cetriaxone | 83/117 (70.9%) | 31/35 (88.6%) | 5/7 (71.4%) | 24/25 (96.0%) | 7/7 (100.0%) | 11/11 (100.0%) |
Cephalexin | 74/119 (62.2%) | 29/36 (80.6%) | 6/7 (85.7%) | 26/28 (92.9%) | 5/7 (71.4%) | 11/711 (100.0%) |